The content is available as a PDF (91.9 KB).
Bibliografía
- 1.Puig-Barberá J., Belenguer A., Goterris M., Brines M.J. Efectividad de la vacuna frente al neumococo en el anciano. Revisión sistemática y metaanálisis. Aten Primaria. 2002;30:269–282. doi: 10.1016/S0212-6567(02)79027-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Dear K., Holden J., Andrews R., Tatham D. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2003;(4) doi: 10.1002/14651858.CD000422. CD000422. [DOI] [PubMed] [Google Scholar]
- 3.Mantagni P., Cutts F., Hall A.J. Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence. Lancet Infect Dis. 2003;3:71–78. doi: 10.1016/s1473-3099(03)00514-0. [DOI] [PubMed] [Google Scholar]
- 4.Fedson D.S., Lise C. Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults. Vaccine. 2004;22:927–946. doi: 10.1016/j.vaccine.2003.09.027. [DOI] [PubMed] [Google Scholar]
- 5.Melegaro A., Edmunds W.J. The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: comparison of meta-analyses. Eur J Epidemiol. 2004;19:353–363. doi: 10.1023/b:ejep.0000024701.94769.98. [DOI] [PubMed] [Google Scholar]
- 6.Jackson L.A., Neuzil K.M., Yu O. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med. 2003;348:1747–1755. doi: 10.1056/NEJMoa022678. [DOI] [PubMed] [Google Scholar]
- 7.Christenson B., Hedlund J., Lundbergh P., Ortqvist A. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J. 2004;23:363–368. doi: 10.1183/09031936.04.00063504. [DOI] [PubMed] [Google Scholar]
- 8.Domínguez A., Salleras L., Fedson D.S. Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain. Clin Infect Dis. 2005;40:1250–1257. doi: 10.1086/429236. [DOI] [PubMed] [Google Scholar]
- 9.Vila Córcoles A., Ochoa Gondar O., Hospital Guardiola I., Llor Vila C., Bria Ferré X., Montañés Boncompte D. Proyecto EVAN-65: evaluación de la efectividad de la vacunación antineumocócica sistemática en mayores de 65 años. Aten Primaria. 2004;33:149–153. doi: 10.1016/S0212-6567(04)79376-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Vila-Córcoles A., Ochoa O., Hospital I. Protective Effects of the 23-valent Pneumococcal polysaccharide vaccine in the elderly population: The EVAN Study. Clin Infect Dis. 2006;43:860–868. doi: 10.1086/507340. [DOI] [PubMed] [Google Scholar]
- 11.De Juanes Pardo J.R. Efectividad de la vacuna antineumocócica de 23 polisacáridos. SEMERGEN. 2005;31:61–66. [Google Scholar]
- 12.Artz A.S., Ershler W.B., Longo D.L. Pneumococcal vaccination and revaccination of older adults. Clin Microbiol Rev. 2003;16:308–318. doi: 10.1128/CMR.16.2.308-318.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]